Shanghai Allist Pharmaceuticals Co., Ltd.
https://www.allist.com.cn/en/index.html
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Shanghai Allist Pharmaceuticals Co., Ltd.
Asia Deal Watch: EpimAb Licenses Bispecific Antibody To Newly Formed Vignette
Also including deals between EpimAb/Vignette, Allist/Jacobio, Rigel/Kissei, Simcere/TargetRx, Altamira/Nuance, PharmaEssentia/Forus and Chugai/LTL.
ArriVent Targets PACC Mutation Market With EGFR TKI Firmonertinib In Lung Cancer
Newly public company ArriVent BioPharma presented Phase Ib results at WCLC for its kinase inhibitor, which could be the first drug available specifically for hard-to-treat PACC mutations.
Innovent/GenFleet Score China’s First KRAS G12C Inhibitor Approval
The nod will help unlock a national market for the partners’ Dupert (fulzerasib) in which roughly 50,000 people are expected to be newly diagnosed with lung cancer harboring the KRAS G12C mutation in 2025. Meanwhile, two other homegrown rivals are also closing in on marketing clearances in China.
Chinese Drug Makers Trim, Boost Pipelines In New R&D Drive
The ranks of B7-H3-targeting antibody-drug conjugates under development in China have seen their first dropout, although elsewhere there are two FGFR2b-directed ADCs with first-in-class potential on the horizon. Meanwhile, there have been other discontinuations of KRAS G12C inhibitors and anti-BCMA CAR-T cell therapies in the country, while new players have surfaced in the areas of mRNA cancer vaccines and amyloid-beta-targeting antibodies for Alzheimer’s disease.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
-
Drug Delivery
- Controlled Release
-
Biotechnology
- Drug Discovery Technologies
- Other Names / Subsidiaries
-
- Allist Pharmaceuticals, Inc.,
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice